• Plenary Lecture
• Meet the Expert
• Symposium
• Joint Symposium
• Working Group
• Research Workshop
  (Korean Only)

Symposium 1. Beyond Bone: Extraskeletal Effects of Anti-Osteoporotic Treatments
Day 2 (June 14, Fri) 11:10-12:25, Room 1

• Cardiovascular Perspectives: Elucidating Bisphosphonate's Broader Clinical Efficacy
  Kyoung Jin Kim (Korea University, Korea)
  CV
  
  
  
• Denosumab and Musculoskeletal Health: Analyzing Its Comprehensive Muscle Benefits
  Jeonghoon Ha (The Catholic University of Korea, Korea)
  CV
  
  
  
• Expanding the Scope of Romosozumab: Insights into Organ System Effects
  Seong Hee Ahn (Inha University, Korea)
  CV
  
  
  

Symposium 2. Advances in Bone Research: Biology, Genetics and Therapeutics
Day 2 (June 14, Fri) 11:10-12:25, Room 2

• Compartment-Specific Skeletal Stem Cells and Their Unique Regulatory Mechanism
  Dongsu Park (Baylor College of Medicine, USA)
  CV
  
  
  
• A Rare Variant Allele of BMPR2 Predisposes to the Onset of a Novel Subtype of Congenital Heterotopic Ossification
  Yonghwan Kim (Sookmyung Women’s University, Korea)
  CV
  
  
  
• Discovery of E3 Ligase as a Potential Therapeutic Target for Osteoporosis
  Se Hwan Mun (Sookmyung Women’s University, Korea)
  CV
  
  
  

Symposium 3. Keynote Symposium
Uncovering Mechanisms of Metabolic Bone Diseases
Day 2 (June 14, Fri) 15:45-17:00, Room 1

• Exploring Mechanisms of Anti-RANKL Treatment Discontinuation
  Koji Ishikawa (Duke University, USA)
  CV
  
  
  
• Illuminating the Dormancy Break: ROI-Based Transcriptomics Approach to Reveal the Mechanism of Bone Lining Cells Reactivation
  Sang Wan Kim (Seoul National University, Korea)
  CV
  
  
  
• Unveiling Sclerostin: A Journey from Discovery to Breakthrough Osteoporosis Treatments
  David W. Dempster (Colombia University, USA)
  CV
  
  
  

Symposium 4. Cutting-Edge Challenges in Osteoporosis Treatments
Day 3 (June 15, Sat) 11:30-12:45, Room 1

• Personalizing Osteoporosis Management: Task Force Update on Goal-Directed Therapy
  Yumie Rhee (Yonsei University, Korea)
  CV
  
  
  
• Navigating MRONJ Risks: The Role of Drug Holidays in IV Bisphosphonate Therapy
  Sung Hye Kong (Seoul National University, Korea)
  CV
  
  
  
• Atypical Femoral Fracture: 2023 Position Statement of the Korean Society for Bone and Mineral Research
  Byung-Woong Jang (Soonchunhyang University, Korea)
  CV
  
  
  

Symposium 5. Frontiers in Osteoimmunology
Day 3 (June 15, Sat) 11:30-12:45, Room 2

• Epigenetics in the Pathogenesis of Rheumatoid Arthritis
  Sung-Ho Park (UNIST, Korea)
  CV
  
  
  
• Advancing Single-Cell Technology: Exploring Diverse Osteoclast Subsets
  Hiroyuki Okada (The University of Tokyo, Japan)
  CV
  
  
  
• Cholesterol Metabolism in Periodontitis Pathogenesis
  Je-Hwang Ryu (Chonnam National University, Korea)
  CV
  
  
  

Symposium 6. Advance in Imaging AI for Fracture Risk Assessment: Unraveling the Time to Come
Day 3 (June 15, Sat) 15:20-16:35, Room 1

• Artificial Intelligence in Fracture Risk Assessment: Landscape View
  Namki Hong (Yonsei University, Korea)
  CV
  
  
  
• CT-Based AI for Fracture Risk Prediction: Biofidelic Finite Element Modelling and Beyond
  Benedikt Helgason (ETH-Zürich, Switzerland)
  CV
  
  
  
• Generative AI and Its Applications to MSK Images
  Kyu-Hwan Jung (Sungkyunkwan University, Korea)
  CV
  
  
  

Symposium 7. Trends in Muscle Aging Research
Day 3 (June 15, Sat) 15:20-16:35, Room 2

• Rejuvenating Stem Cells and Niche to Counteract Muscle Aging
  Jong-Sun Kang (Sungkyunkwan University, Korea)
  CV
  
  
  
• Insulin Promotes Skeletal Muscle Growth via Stimulation of Motor Neurons
  Jong-Woo Sohn (KAIST, Korea)
  CV
  
  
  
• Molecular Regulation of Skeletal Muscle Stem Cell Aging
  Tom H Cheung (Hong Kong University of Science and Technology, Hong Kong)
  CV
  
  
  

Luncheon Symposium 1
Day 2 (June 14, Fri) 12:25-12:40, Room 1

• Navigating Postmenopausal Bone Health: The Efficacy of Raloxifene in Osteopenia and Osteoporosis
  Beom-Jun Kim (University of Ulsan)
  CV
  
  
  

Luncheon Symposium 2
Day 3 (June 15, Sat) 12:45-13:00, Room 1

• First Steps Matters: Achieving Treatment Goals with Romosozumab and Denosumab
  Seong-Eun Byun (CHA University, Korea)
  CV